Structured evidence table for Chlorella Blood Pressure Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Chlorella Blood Pressure Meta-Analysis | vulgaris) consumption on cardiovascular disease risk factors in patients with non-alcoholic fatty liver disease (NAFLD). | 1 | Jafari A (2026) | The beneficial effects of Chlorella vulgaris supplementation on health-related indices in patients with non-alcoholic fatty liver disease: a GRADE-assessed systematic review and meta-analysis. |
| Chlorella Blood Pressure Meta-Analysis | However, all included studies were conducted in Iran, limiting the generalizability of these findings, and the certainty of evidence was rated as very low due to risk of bias, indicating that the results should be interpreted with caution. | 1 | Jafari A (2026) | The beneficial effects of Chlorella vulgaris supplementation on health-related indices in patients with non-alcoholic fatty liver disease: a GRADE-assessed systematic review and meta-analysis. |
| Chlorella Blood Pressure Meta-Analysis | This systematic review and meta-analysis aimed to assess the impact of Chlorella vulgaris (C. | 1 | Jafari A (2026) | The beneficial effects of Chlorella vulgaris supplementation on health-related indices in patients with non-alcoholic fatty liver disease: a GRADE-assessed systematic review and meta-analysis. |
| Chlorella Blood Pressure Meta-Analysis | Chlorella 5 7 8 9 10 Emerging evidence suggests that supplementation withand spirulina may be associated with improvements in metabolic parameters such as insulin sensitivity, lipid profiles, and hepatic steatosis markers while simultaneously reducing systemic inflammatory burden and oxidative stress. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
| Chlorella Blood Pressure Meta-Analysis | We also discuss clinical evidence, safety considerations, and translational perspectives, highlighting current knowledge gaps and future research directions necessary for the rational development of microalgae-based interventions in preventive and integrative medicine. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
| Chlorella Blood Pressure Meta-Analysis | 2 7 19 In spirulina, phycobiliproteins, particularly phycocyanin, are the dominant pigment-derived bioactives, with documented antioxidant and anti-inflammatory activity and emerging evidence for metabolic signaling effects including Nrf2 activation and the attenuation of oxidative stress in preclinical models [,,]. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
| Chlorella Blood Pressure Meta-Analysis | Chlorella Arthrospira Microalgae represent a diverse group of aquatic photosynthetic microorganisms and a rich source of bioactive compounds with significant potential in functional foods, nutraceuticals, and preventive medicine. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
Source documents